Drug-induced ocular inflammatory diseases

Frederick W. Fraunfelder

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Ocular inflammation can arise in the form of conjunctivitis, uveitis, episcleritis and scleritis. The uveitides can be subdivided by anatomical location into anterior and posterior uveitis or categorized by location of inflammation, e.g., iritis, pars planitis or iridocyclitis. Multiple drugs have been associated with ocular inflammation and much has been written on the subject. Discussed here is a sampling of drugs representing classes of medication associated with ocular inflammation. However, this is not a comprehensive list and interested readers are encouraged to access the National Registry of Drug-Induced Ocular Side Effects (Casey Eye Institute, Portland, Oregon, www.eyedrugregistry.com) or the textbook Drug-Induced Ocular Side Effects for further information (1). The agents discussed may be administered systemically, topically or intra-camerally (inside the eye). The mechanism behind ocular inflammation is frequently unknown. Prevention and treatment are based upon physician recognition and withdrawal of the drug in some instances. Consultation with an ophthalmologist is recommended, as many types of ocular inflammation can threaten vision.

Original languageEnglish (US)
Pages (from-to)117-123
Number of pages7
JournalDrugs of Today
Volume43
Issue number2
DOIs
StatePublished - Feb 2007

Fingerprint

Eye Diseases
Pharmaceutical Preparations
Inflammation
Scleritis
Uveitis
Pars Planitis
Posterior Uveitis
Iritis
Iridocyclitis
Anterior Uveitis
Conjunctivitis
Textbooks
Registries
Referral and Consultation
Physicians

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology (medical)
  • Pharmacology

Cite this

Drug-induced ocular inflammatory diseases. / Fraunfelder, Frederick W.

In: Drugs of Today, Vol. 43, No. 2, 02.2007, p. 117-123.

Research output: Contribution to journalArticle

Fraunfelder, Frederick W. / Drug-induced ocular inflammatory diseases. In: Drugs of Today. 2007 ; Vol. 43, No. 2. pp. 117-123.
@article{c33d272c3b1b4f1eab6f739f2ef74590,
title = "Drug-induced ocular inflammatory diseases",
abstract = "Ocular inflammation can arise in the form of conjunctivitis, uveitis, episcleritis and scleritis. The uveitides can be subdivided by anatomical location into anterior and posterior uveitis or categorized by location of inflammation, e.g., iritis, pars planitis or iridocyclitis. Multiple drugs have been associated with ocular inflammation and much has been written on the subject. Discussed here is a sampling of drugs representing classes of medication associated with ocular inflammation. However, this is not a comprehensive list and interested readers are encouraged to access the National Registry of Drug-Induced Ocular Side Effects (Casey Eye Institute, Portland, Oregon, www.eyedrugregistry.com) or the textbook Drug-Induced Ocular Side Effects for further information (1). The agents discussed may be administered systemically, topically or intra-camerally (inside the eye). The mechanism behind ocular inflammation is frequently unknown. Prevention and treatment are based upon physician recognition and withdrawal of the drug in some instances. Consultation with an ophthalmologist is recommended, as many types of ocular inflammation can threaten vision.",
author = "Fraunfelder, {Frederick W.}",
year = "2007",
month = "2",
doi = "10.1358/dot.2007.43.2.1050789",
language = "English (US)",
volume = "43",
pages = "117--123",
journal = "Drugs of Today",
issn = "1699-3993",
publisher = "Prous Science",
number = "2",

}

TY - JOUR

T1 - Drug-induced ocular inflammatory diseases

AU - Fraunfelder, Frederick W.

PY - 2007/2

Y1 - 2007/2

N2 - Ocular inflammation can arise in the form of conjunctivitis, uveitis, episcleritis and scleritis. The uveitides can be subdivided by anatomical location into anterior and posterior uveitis or categorized by location of inflammation, e.g., iritis, pars planitis or iridocyclitis. Multiple drugs have been associated with ocular inflammation and much has been written on the subject. Discussed here is a sampling of drugs representing classes of medication associated with ocular inflammation. However, this is not a comprehensive list and interested readers are encouraged to access the National Registry of Drug-Induced Ocular Side Effects (Casey Eye Institute, Portland, Oregon, www.eyedrugregistry.com) or the textbook Drug-Induced Ocular Side Effects for further information (1). The agents discussed may be administered systemically, topically or intra-camerally (inside the eye). The mechanism behind ocular inflammation is frequently unknown. Prevention and treatment are based upon physician recognition and withdrawal of the drug in some instances. Consultation with an ophthalmologist is recommended, as many types of ocular inflammation can threaten vision.

AB - Ocular inflammation can arise in the form of conjunctivitis, uveitis, episcleritis and scleritis. The uveitides can be subdivided by anatomical location into anterior and posterior uveitis or categorized by location of inflammation, e.g., iritis, pars planitis or iridocyclitis. Multiple drugs have been associated with ocular inflammation and much has been written on the subject. Discussed here is a sampling of drugs representing classes of medication associated with ocular inflammation. However, this is not a comprehensive list and interested readers are encouraged to access the National Registry of Drug-Induced Ocular Side Effects (Casey Eye Institute, Portland, Oregon, www.eyedrugregistry.com) or the textbook Drug-Induced Ocular Side Effects for further information (1). The agents discussed may be administered systemically, topically or intra-camerally (inside the eye). The mechanism behind ocular inflammation is frequently unknown. Prevention and treatment are based upon physician recognition and withdrawal of the drug in some instances. Consultation with an ophthalmologist is recommended, as many types of ocular inflammation can threaten vision.

UR - http://www.scopus.com/inward/record.url?scp=34147198831&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34147198831&partnerID=8YFLogxK

U2 - 10.1358/dot.2007.43.2.1050789

DO - 10.1358/dot.2007.43.2.1050789

M3 - Article

C2 - 17353948

AN - SCOPUS:34147198831

VL - 43

SP - 117

EP - 123

JO - Drugs of Today

JF - Drugs of Today

SN - 1699-3993

IS - 2

ER -